SCHEMBL873963

SCHEMBL873963

C/C=C(\C)C(=O)OC/C=C/c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.49
MMP2 P08253 1/20 0.49
MMP9 P14780 1/20 0.49
MMP12 P39900 1/20 0.49
TDP1 Q9NUW8 2/20 0.48
ALDH1A1 P00352 1/20 0.48
MAPT P10636 1/20 0.48
RECQL P46063 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
IDO1 P14902 2/20 0.47
PAM P19021 1/20 0.47
CACNA1B Q00975 4/20 0.47
GLA P06280 1/20 0.44
NPC1 O15118 2/20 0.44
POLB P06746 1/20 0.44
RAB9A P51151 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4315631 1.00 MMP1 (0.49) MMP1MMP2MMP9MMP12TDP1
SCHEMBL873965 1.00 MMP1 (0.49) MMP1MMP2MMP9MMP12TDP1
SCHEMBL873964 1.00 MMP1 (0.49) MMP1MMP2MMP9MMP12TDP1
SCHEMBL29619800 0.89 AKR1C3 (0.51) MMP1MMP2MMP9MMP12TDP1
SCHEMBL23882016 0.87 MMP1 (0.51) MMP1MMP2MMP9MMP12TDP1
SCHEMBL20539359 0.87 MMP1 (0.51) MMP1MMP2MMP9MMP12TDP1
SCHEMBL27870200 0.86 MMP1 (0.46) MMP1MMP2MMP9MMP12TDP1
SCHEMBL868886 0.86 ALDH1A1 (0.49) MMP1MMP2MMP9MMP12TDP1
SCHEMBL9762368 0.86 IDO1 (0.57) MMP1MMP2MMP9MMP12TDP1
SCHEMBL75626 0.84 CACNA1B (0.50) MMP1MMP2MMP9MMP12TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250212873-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-07-03 US claimed
EP-4482306-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-01 EP claimed
WO-2023192424-A1 VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-05 WO claimed
US-20250212873-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-07-03 US disclosed
EP-4482306-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-01 EP disclosed
WO-2023192424-A1 VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-05 WO disclosed
CN-110891615-B System and method for selecting and releasing fragrance 阿甘香气及精细化学有限公司 2022-08-05 CN disclosed
US-20220071933-A1 COMBINATION REMEDY SYMRISE AG (DE) 2022-03-10 US disclosed
WO-2020147977-A1 COMBINATION REMEDY SYMRISE AG (DE) 2020-07-23 WO disclosed
US-10006151-B2 Polyurethane fiber TORAY OPELONTEX CO., LTD. (JP) 2018-06-26 US disclosed
US-9959392-B2 Olfactory signature and odorant mixture having the same YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2018-05-01 US disclosed
WO-2006068276-A1 HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR SHOWA DENKO K.K. (JP) 2006-06-29 WO disclosed
WO-2006010087-A1 ROLLER FOR PROVIDING BENEFITS TO FABRIC THE PROCTER & GAMBLE COMPANY (US) 2006-01-26 WO disclosed
US-20060005333-A1 Roller for providing benefits to fabric PROCTER & GAMBLE COMPANY, THE 2006-01-12 US disclosed
US-20050245407-A1 Fragrance composition KAO CORPORATION (JP) 2005-11-03 US disclosed
EP-1561476-A1 DEODORANT COMPOSITION Takasago International Corporation (JP) 2005-08-10 EP disclosed
EP-1552814-A1 FRAGRANCE COMPOSITION Kao Corporation (JP) 2005-07-13 EP disclosed
EP-0244822-B1 BALSAMIC FRAGRANCE COMPOSITION AND PROCESS FOR PREPARATION HENKEL CORPORATION (US) 1991-03-06 EP disclosed
EP-0244822-A2 Balsamic fragrance composition and process for preparation HENKEL CORPORATION (US) 1987-11-11 EP disclosed
US-4661285-A FROM CAMPHENE, ETHYLHALOACETATE, AND DI-TERT-BUTYL PEROXIDE NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) 1987-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220071933-A1 COMBINATION REMEDY GPR119, GLP1R, GIPR MMP1 3880/4885MMP2 4072/4885MMP9 4270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.